Effect of discontinuation of ticagrelor and switching-over to other P2Y12 agents in patients with acute coronary syndrome: a single-center real-world experience from India

BACKGROUND: Dual antiplatelet therapy is the current standard of care after acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI). We intended to study the pattern of use of ticagrelor in patients with acute coronary syndrome undergoing PCI and the effect of switching over to ot...

Descripción completa

Detalles Bibliográficos
Autores principales: Senguttuvan, Nagendra Boopathy, Sankaran, Ramesh, Rajeev, Yashasvi, Thaiyal, Devi, Mathew, Angel, Dharsini, K., Marcelene, Divya, Kalsingh, Maria Jusler, Sahu, Sujit Kumar, Sampath, Aravind, Prem Kumar, K. J., Parthasarathy, Harikrishnan, Louis, Amal, Gnanaraj, Anand, Reddy, K. N., Abraham, K. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801539/
https://www.ncbi.nlm.nih.gov/pubmed/33428005
http://dx.doi.org/10.1186/s43044-020-00128-3

Ejemplares similares

Ejemplares similares